Nu-Med Plus, Inc. NUMD
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 22.60K | 13.20K | 9.80K | 10.10K | 10.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.60K | 13.20K | 9.80K | 10.10K | 10.40K |
| Operating Income | -22.60K | -13.20K | -9.80K | -10.10K | -10.40K |
| Income Before Tax | 19.70K | -15.90K | -12.60K | -12.00K | -11.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.70K | -15.90K | -12.60K | -12.00K | -11.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.70K | -15.90K | -12.60K | -12.00K | -11.70K |
| EBIT | -22.60K | -13.20K | -9.80K | -10.10K | -10.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 83.55M | 83.55M | 83.55M | 83.55M | 83.55M |
| Average Diluted Shares Outstanding | 83.55M | 83.55M | 83.55M | 83.55M | 83.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |